Free Trial
→ This company will win the AI race (From Porter & Company) (Ad) Free VRDN Stock Alerts

Viridian Therapeutics (VRDN) SEC Filings & 10K Form

Viridian Therapeutics logo
$20.14 -1.50 (-6.93%)
(As of 11/15/2024 ET)
Compare

Recent Viridian Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
11/14/2024
4:52 PM		Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:53 PM		Venrock Opportunities Fund, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:50 PM		PERCEPTIVE ADVISORS LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:33 PM		Paradigm Biocapital Advisors LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:15 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:15 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
11:33 AM		STATE STREET CORP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
09/30/2024
6:12 PM		Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:10 PM		Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
8:00 PM		Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13D/A
09/17/2024
8:00 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:07 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/12/2024
4:25 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:28 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/10/2024
6:11 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:25 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:01 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:31 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
3:25 PM		Gheuens Sarah (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:16 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:05 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
05/08/2024
6:51 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:09 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
7:30 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/26/2024
7:30 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/26/2024
7:32 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
04/26/2024
7:32 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
04/26/2024
7:34 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
04/26/2024
7:34 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
04/01/2024
5:38 PM		Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13D/A
04/01/2024
5:32 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund GP LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:34 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
7:28 PM		Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
02/14/2024
8:22 AM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
01/29/2024
3:53 PM		PERCEPTIVE ADVISORS LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G
01/29/2024
2:26 PM		BlackRock Inc. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
01/24/2024
5:44 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund GP LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:13 AM		STATE STREET CORP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G
01/19/2024
4:22 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:32 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
01/12/2024
3:31 PM		Ciulla Thomas (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
01/10/2024
7:53 AM		FMR LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G
01/08/2024
7:08 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
10:45 AM		Meisner Lara (Reporting)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
7:15 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:19 PM		Humer Kristian (Reporting)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2023
3:17 PM		Venrock Opportunities Fund, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G
12/07/2023
3:22 PM		Humer Kristian (Reporting)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:04 PM		Meisner Lara (Reporting)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VRDN) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...
Porter & Company | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored